Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 694

Debiopharm produces GenePoc investment

Debiopharm has committed an eight-figure sum to recently acquired subsidiary GenePoc and has also agreed to set up a new production line.

Sep 1, 2016

Rev1 fires up $22m Ohio fund

The fund's LPs include Nationwide, Cardinal Health, Worthington Industries, Crane Group, AEP Ohio, Dispatch Printing Company, State Auto Insurance and IGS Energy.

Sep 1, 2016

Mitra Biotech writes $27m series B script

A Tata Capital subsidiary was among the investors in a $27.4m round that will support development of Canscript, Mitra Biotech's oncology treatment analytics technology.

Sep 1, 2016

Shyft keys in $12.5m

Corporates McKesson and Medidata Solutions came on board to help life sciences cloud analytics platform Shyft Analytics' overall funding to $31.5m.

Aug 31, 2016

Mitra Biotech writes $27m series B script

A Tata Capital subsidiary was among the investors in a $27.4m round that will support development of Canscript, Mitra Biotech's oncology treatment analytics technology.

Aug 31, 2016

Legend Capital discloses $495m of new funds

The CVC unit has launched a $270m tech fund and a $225m healthcare fund this year, while sister firm Hony Capital has raised a $2.2bn private equity fund.

Aug 31, 2016

Arcus Biosciences reveals $120m of funding

Celgene, Novartis, GV and Taiho Ventures are among the backers that provided the funding for the Stanford-backed immuno-oncology company over two rounds.

Aug 31, 2016

Arcus Biosciences reveals $120m of funding

Celgene, Novartis, GV and Taiho Ventures are among the backers that provided the funding for the immuno-oncology company over two rounds.

Aug 30, 2016
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here